NAICS 325414 — Biological Product (except Diagnostic) Manufacturing
Contracts in this directory: 5. Total obligated: $29,287,086,350.27.
Federal contract awards with obligation activity November 9, 2023 – November 9, 2026. Data through November 9, 2026.
No contracts in this NAICS code end in the next 12 months.
Contracts
| Recipient | Award ID (PIID) | Agency | NAICS | Obligated | Potential value | Ends | Source |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | W15QKN21C0012 | Department of Defense | 325414 | $22,220,268,131.36 | $22,570,268,131.36 | 2023-06-30 | USAspending |
| Pfizer Inc. | W58P0521C0002 | Agency for International Development | 325414 | $4,150,835,100.00 | $6,859,517,906.00 | 2024-02-29 | USAspending |
| Modernatx, Inc. | 75A50120C00034 | Department of Health and Human Services | 325414 | $1,754,345,480.45 | $1,754,345,480.45 | 2025-06-15 | USAspending |
| Emergent Product Development Gaithersburg Inc. | 75A50119C00071 | Department of Health and Human Services | 325414 | $857,637,641.46 | $857,637,641.46 | 2026-09-30 | USAspending |
| Advanced Technology International Includes 1 task/delivery order(s) under parent 75A50123D00003. | 75A50124F61002 | Department of Health and Human Services | 325414 | $303,999,997.00 | $375,999,997.00 | 2030-03-01 | USAspending |
| Total of all 5 contracts in this group | $29,287,086,350.27 | $32,417,769,156.27 | |||||
Showing the top 5 of 5 contracts in this group. Group total (all 5): $29,287,086,350.27 obligated, $32,417,769,156.27 potential value. The full list and CSV export come with the paid plan — see Pricing.